Skip Navigation


NDT Advance Access originally published online on October 12, 2007
Nephrology Dialysis Transplantation 2008 23(1):385-386; doi:10.1093/ndt/gfm701
This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow All Versions of this Article:
23/1/385    most recent
gfm701v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (2)
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Nellessen, C. M.
Right arrow Articles by Rabe, C.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Nellessen, C. M.
Right arrow Articles by Rabe, C.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

© The Author [2007]. Published by Oxford University Press on behalf of ERA-EDTA. All rights reserved. For Permissions, please e-mail: journals.permissions@oxfordjournals.org


Diffuse alveolar haemorrhage in a systemic lupus erythematosus patient successfully treated with rituximab: a case report

Cordula M. Nellessen1, Uwe Pöge2, Karl A. Brensing2, Tilman Sauerbruch1, Hans-Ulrich Klehr1 and Christian Rabe1

1Universitätsklinikum Bonn, Medizinische Klinik und Poliklinik I – Allgemeine Innere Medizin, Sigmund-Freud-Str. 25, D-53127 Bonn, Germany and 2Praxis für Nieren- und Hochdruckkrankheiten, Rheinstr. 37, 53179 Bonn, Germany

Correspondence and offprint requests to: Cordula M. Nellessen, Department of Medicine I, University of Bonn, Sigmund-Freud-Str. 25, 53105 Bonn, Germany. Tel: +49-228-287-15507; Fax: +49-228-28714322; E-mail: cordula.nellessen@ukb.uni-bonn.de

Keywords: diffuse alveolar haemorrhage; rituximab; systemic lupus erythematosus

The first 10% of the full text of this article appears below.



   Introduction
 
Diffuse alveolar haemorrhage (DAH) often mimics, clinically and radiologically, severe pneumonia or ARDS [1]. The causes of DAH include a variety of non-infectious diseases, e.g. collagen vascular disease. In DAH associated with SLE, a regimen of corticosteroids combined with cyclophosphamide and plasma exchange is generally recommended [2]. We describe here a ventilated SLE patient with DAH refractory to standard therapies. To our knowledge, this represents the first successful application of rituximab in DAH.



   Case report
 
A 29-year-old North African female presented to our institution . . . [Full Text of this Article]



   Discussion
 

Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
 Rheumatology (Oxford)Home page
C. B. Narshi, S. Haider, C. M. Ford, D. A. Isenberg, and I. P. Giles
Rituximab as early therapy for pulmonary haemorrhage in systemic lupus erythematosus
Rheumatology, November 19, 2009; (2009) kep356v1.
[Full Text] [PDF]

Home page
 LupusHome page
D. Todd and K. Costenbader
Dyspnoea in a young woman with active systemic lupus erythematosus
Lupus, August 1, 2009; 18(9): 777 - 784.
[Abstract] [PDF]